<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Acne Vulgaris - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Acne Vulgaris</span>
        </nav>

        <header class="page-header">
            <h1>Acne Vulgaris</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Complex</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0011438" target="_blank">
                        MONDO:0011438
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Inflammatory skin disease</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Pilosebaceous unit disorder</span>
                
            </div>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">7</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">18</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            
            
            <a class="stat-link" href="#differentials">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Differentials</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#datasets">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Datasets</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#trials">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Trials</div>
            </div>
            </a>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">7</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Follicular keratinization</div>
                
                <div class="item-desc">Dysregulated keratinocyte differentiation and desquamation within the follicular epithelium promotes retention hyperkeratosis.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        keratinocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000312" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32748305" target="_blank">PMID:32748305</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Acne pathogenesis is attributed to four key factors: excess sebum production, hyperproliferation of Cutibacterium acnes (C. acnes, formerly called Propionibacterium acnes) bacteria, hyperkeratinization of the pilosebaceous follicles, and inflammatory mechanisms"</div>
                
                
                <div class="evidence-explanation">This review explicitly identifies hyperkeratinization of the pilosebaceous follicles as a key factor in acne pathogenesis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Microcomedone formation</div>
                
                <div class="item-desc">Follicular obstruction from retained keratin and sebum leads to early microcomedone development that seeds later visible comedones.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        keratinocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000312" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32748305" target="_blank">PMID:32748305</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Acne pathogenesis is attributed to four key factors: excess sebum production, hyperproliferation of Cutibacterium acnes (C. acnes, formerly called Propionibacterium acnes) bacteria, hyperkeratinization of the pilosebaceous follicles, and inflammatory mechanisms"</div>
                
                
                <div class="evidence-explanation">Follicular hyperkeratinization is the initiating event that drives microcomedone formation in acne.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Sebum overproduction</div>
                
                <div class="item-desc">Androgen and IGF-1 signaling increase sebocyte activity, elevating sebum output and creating a lipid-rich follicular environment.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        sebocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000317" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        lipid metabolism
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006629" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32748305" target="_blank">PMID:32748305</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"In acne, mTORC1 mediates sebaceous gland hyperproliferation, lipid synthesis, and hyperplasia of keratinocytes"</div>
                
                
                <div class="evidence-explanation">This review links sebaceous gland hyperproliferation and lipid synthesis to acne pathogenesis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Sebum compositional change</div>
                
                <div class="item-desc">Altered fatty acid ratios and oxidation products within sebum contribute to comedogenesis and inflammatory signaling.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        sebocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000317" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        lipid metabolism
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006629" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20871834" target="_blank">PMID:20871834</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Altered ratio between saturated and unsaturated fatty acids has been indicated as an important feature to be considered in addition to the altered amount of specific fatty acids such as linoleic acid"</div>
                
                
                <div class="evidence-explanation">This review highlights altered sebum fatty acid composition as a pathophysiologic feature of acne.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">C. acnes follicular colonization</div>
                
                <div class="item-desc">Cutibacterium acnes expands within occluded follicles and contributes to lesion progression from noninflammatory comedones to inflamed papules.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        sebocyte
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000317" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24062871" target="_blank">PMID:24062871</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Propionibacterium acnes colonizes the duct of the sebaceous follicle, causing an innate immune response and the progression from a so-called noninflammatory comedo to an inflammatory papule, pustule, or nodule."</div>
                
                
                <div class="evidence-explanation">This review describes C. acnes colonization and its role in lesion progression.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Inflammasome activation</div>
                
                <div class="item-desc">Innate immune sensing activates inflammasome pathways that amplify inflammatory signaling in acne lesions.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        macrophage
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000235" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        inflammatory response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006954" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fimmu.2023.1075834" target="_blank">DOI:10.3389/fimmu.2023.1075834</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The inflammasomes are intracellular multimeric protein complexes consisting of an innate immune sensor, the adapter protein ASC and the inflammatory caspases-1 and/or -11 and are important for the host defense against pathogens."</div>
                
                
                <div class="evidence-explanation">This review explains inflammasome activation, a key mechanism implicated in acne inflammation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Cytokine-driven inflammation</div>
                
                <div class="item-desc">Inflammasome and innate immune activation drive cytokine release that recruits neutrophils and sustains inflammatory lesion formation.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        neutrophil
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000775" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        inflammatory response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006954" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://bioregistry.io/DOI:10.3389/fimmu.2023.1075834" target="_blank">DOI:10.3389/fimmu.2023.1075834</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The inflammasomes are intracellular multimeric protein complexes consisting of an innate immune sensor, the adapter protein ASC and the inflammatory caspases-1 and/or -11 and are important for the host defense against pathogens."</div>
                
                
                <div class="evidence-explanation">Inflammasome activation supports downstream cytokine-mediated inflammation in acne lesions.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">6</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Comedones
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0040137" target="_blank">
                            HP:0040137
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24062871" target="_blank">PMID:24062871</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"evidence has emerged supporting a role for inflammation at all stages of acne lesion development, perhaps subclinically even before comedo formation"</div>
                
                
                <div class="evidence-explanation">This review discusses the role of comedones as a key lesion type in acne pathogenesis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Inflammatory papules
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0030350" target="_blank">
                            HP:0030350
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/24062871" target="_blank">PMID:24062871</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"the progression from a so-called noninflammatory comedo to an inflammatory papule, pustule, or nodule"</div>
                
                
                <div class="evidence-explanation">This review describes the progression from comedones to inflammatory papules in acne lesion development.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Pustules
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0200039" target="_blank">
                            HP:0200039
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12113648" target="_blank">PMID:12113648</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Localized pustular eruptions are seen on the hands and feet in adults with pustulosis palmaris et plantaris and acrodermatitis continua (both of which may be variants of psoriasis); on the face in patients with acne vulgaris, rosacea, and perioral dermatitis"</div>
                
                
                <div class="evidence-explanation">This review identifies pustular eruptions on the face as a characteristic feature of acne vulgaris.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Nodules and cysts
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0033188" target="_blank">
                            HP:0033188
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/21062102" target="_blank">PMID:21062102</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Severe nodular acne, defined as grade 4 or 5 acne on the Investigator&#39;s Static Global Assessment scale, is a skin condition characterized by intense erythema, inflammation, nodules, cysts, and scarring."</div>
                
                
                <div class="evidence-explanation">This review defines severe nodular acne as characterized by nodules and cysts with associated inflammation and scarring potential.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Post-inflammatory hyperpigmentation
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0000953" target="_blank">
                            HP:0000953
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34468934" target="_blank">PMID:34468934</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"the inflammatory processes of acne stimulate excess melanogenesis and abnormal melanin deposition, leading to pigmentary sequelae known as post-inflammatory hyperpigmentation"</div>
                
                
                <div class="evidence-explanation">This paper specifically describes the pathogenesis of acne-induced post-inflammatory hyperpigmentation through excess melanin production.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Scarring
                    
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001075" target="_blank">
                            HP:0001075
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29344322" target="_blank">PMID:29344322</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This review focuses on atrophic scars, the most common type of acne scar."</div>
                
                
                <div class="evidence-explanation">This review confirms atrophic scars as the most common type of acne scarring.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">🧬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    Polygenic susceptibility
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Associated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32748305" target="_blank">PMID:32748305</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"It is known that multiple factors impact acne pathophysiology, including genetic, hormonal, inflammatory, and environmental influences."</div>
                
                
                <div class="evidence-explanation">This review explicitly identifies genetic factors as one of the key influences on acne pathophysiology.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40689430" target="_blank">PMID:40689430</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Both GWAS and single gene disorders unequivocally indicate stem/progenitor cell maintenance and cellular migration as the most important processes in the pathogenesis of acne."</div>
                
                
                <div class="evidence-explanation">This genetics review connects GWAS and monogenic findings to core biological processes underlying acne susceptibility.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    Candidate gene families
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Associated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37662507" target="_blank">PMID:37662507</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"some genes (such as IL, TNF, RETN, CYP family, MMPs and TIMPs genes et al) are associated with acne vulgaris and may affect the progression and prognosis of the disease."</div>
                
                
                <div class="evidence-explanation">This review summarizes multiple gene families repeatedly implicated in acne susceptibility and outcomes.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    RETN-420C&gt;G and IL6-572G&gt;C polymorphisms
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Associated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35279931" target="_blank">PMID:35279931</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"There is a strong correlation between RETN-420 and IL6-572 polymorphisms and acne susceptibility; the RETN-420G and IL6-572C alleles increase the risk of acne development."</div>
                
                
                <div class="evidence-explanation">This study reports RETN-420 and IL6-572 risk alleles associated with acne susceptibility.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    TNFR2 M196R and TLR2 Arg753Gln polymorphisms
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Associated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20861605" target="_blank">PMID:20861605</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The 196R allele of TNFR2 M196R as well as the 753Gln allele of TLR2 Arg753Gln are risk factors for acne vulgaris in Chinese Han patients, further supporting the contribution of inflammatory cytokines to the pathogenesis of acne."</div>
                
                
                <div class="evidence-explanation">This study links TNFR2 and TLR2 risk alleles to acne susceptibility in a Chinese Han cohort.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">18</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Topical retinoids
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000237" target="_blank">
                            MAXO:0000237
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">First-line treatment that normalizes follicular keratinization, reduces comedone formation, and has anti-inflammatory effects. Examples include tretinoin, adapalene, and tazarotene.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/30674002" target="_blank">PMID:30674002</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Topical retinoids are safe and efficacious for the treatment of acne vulgaris."</div>
                
                
                <div class="evidence-explanation">This systematic review confirms the safety and efficacy of topical retinoids for acne treatment.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Trifarotene
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000237" target="_blank">
                            MAXO:0000237
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Topical retinoid selective for retinoic acid receptor gamma with evidence for reducing comedonal and inflammatory lesions, including truncal acne.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36927117" target="_blank">PMID:36927117</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Large-scale randomized, controlled clinical trials have demonstrated trifarotene to be safe, well tolerated, and efficacious in reducing both comedones and papules/pustules of acne."</div>
                
                
                <div class="evidence-explanation">This review summarizes randomized trials showing trifarotene efficacy across comedonal and inflammatory acne lesions.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Benzoyl peroxide
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001021" target="_blank">
                            MAXO:0001021
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Antimicrobial agent that kills C. acnes through oxidative damage without promoting antibiotic resistance. Also has mild comedolytic activity.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19761357" target="_blank">PMID:19761357</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"BPO-containing combinations do not induce bacterial resistance and are important first-line treatments for mild to moderate acne vulgaris."</div>
                
                
                <div class="evidence-explanation">This review establishes benzoyl peroxide as an important first-line treatment for acne that does not promote bacterial resistance.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Topical antibiotics
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000061" target="_blank">
                            MAXO:0000061
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Clindamycin and erythromycin reduce C. acnes populations and have anti-inflammatory effects. Should be combined with benzoyl peroxide to prevent resistance.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/16086756" target="_blank">PMID:16086756</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"topical antibiotics remain one of the cornerstones of acne management"</div>
                
                
                <div class="evidence-explanation">This systematic review confirms topical antibiotics as a cornerstone treatment for acne.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Clindamycin/adapalene/benzoyl peroxide gel
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Triple-combination topical therapy for moderate to severe acne, combining clindamycin phosphate, adapalene, and benzoyl peroxide for long-term use.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41552868" target="_blank">PMID:41552868</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"At week 24, 67% of participants achieved treatment success, and significant reductions from baseline in inflammatory (88%) and noninflammatory (68%) lesions were observed (p &lt; 0.001, both)."</div>
                
                
                <div class="evidence-explanation">This pooled analysis supports long-term efficacy of the triple-combination gel.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Oral antibiotics
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000061" target="_blank">
                            MAXO:0000061
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Tetracyclines (doxycycline, minocycline) are used for moderate-to-severe inflammatory acne. Have both antimicrobial and anti-inflammatory effects, but prolonged use contributes to antimicrobial resistance and requires stewardship.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28542914" target="_blank">PMID:28542914</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"isotretinoin therapy reduced acne lesion counts by a clinically relevant amount, and always by a greater amount than control, which was either placebo (two studies), oral antibiotics (seven studies) or other control"</div>
                
                
                <div class="evidence-explanation">This systematic review confirms oral antibiotics as an established comparator treatment for acne in clinical trials.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36568833" target="_blank">PMID:36568833</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The overuse of topical and/or systemic antibiotics, the long treatment courses used for acne, and the availability of over-the-counter antibiotic preparations, have led to the worldwide emergence of resistant strains in acne patients."</div>
                
                
                <div class="evidence-explanation">This review documents antibiotic resistance concerns tied to prolonged acne antibiotic use, supporting stewardship in treatment.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Oral isotretinoin
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000237" target="_blank">
                            MAXO:0000237
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Systemic retinoid reserved for severe, recalcitrant acne. Addresses all four pathogenic factors but requires careful monitoring due to teratogenicity and other adverse effects.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/33085149" target="_blank">PMID:33085149</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Oral isotretinoin is the most effective treatment for moderate to severe acne and its side effects are mostly dose-dependent."</div>
                
                
                <div class="evidence-explanation">This systematic review confirms oral isotretinoin as the most effective treatment for moderate to severe acne.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Hormonal therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000283" target="_blank">
                            MAXO:0000283
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Combined oral contraceptives and spironolactone reduce androgen effects on sebaceous glands. Used in female patients with hormonal acne patterns.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28492054" target="_blank">PMID:28492054</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Hormone-based therapies including combined oral contraceptive medications and spironolactone are considered effective therapies to treat adult acne in women."</div>
                
                
                <div class="evidence-explanation">This systematic review confirms the efficacy of hormonal therapies including oral contraceptives and spironolactone for treating acne in women.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Chemical peels
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001417" target="_blank">
                            MAXO:0001417
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Organic acid-based peels are used to exfoliate acne-prone skin and reduce lesion counts, with agent selection tailored to patient tolerability.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/37894698" target="_blank">PMID:37894698</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The findings of this comprehensive bibliographic review indicate that organic acid-based chemical peels represent effective and safe treatment options for individuals with acne-prone skin."</div>
                
                
                <div class="evidence-explanation">This review supports organic acid chemical peels as effective and safe adjuncts for acne-prone skin.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Azelaic acid peel
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001417" target="_blank">
                            MAXO:0001417
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Azelaic acid peels reduce sebum and lesion burden as a nonpharmacologic option for facial acne.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/31455112" target="_blank">PMID:31455112</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Peels with 30% AZA reduced acne lesions and normalized the activity of the sebaceous glands."</div>
                
                
                <div class="evidence-explanation">This study reports acne lesion reduction and sebum normalization with 30% azelaic acid peels.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Chemical peels for acne scarring
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001417" target="_blank">
                            MAXO:0001417
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Medium-depth peels such as glycolic acid and trichloroacetic acid are used to improve atrophic acne scars.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39483653" target="_blank">PMID:39483653</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"A 30% TCA peel is efficacious and well-tolerated for mild-to-moderate acne scars."</div>
                
                
                <div class="evidence-explanation">This split-face study supports TCA peels for improving acne scarring.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Ablative fractional CO2 laser
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001578" target="_blank">
                            MAXO:0001578
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Ablative fractional CO2 laser is used for atrophic acne scars but can cause erythema, dyspigmentation, and prolonged recovery.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41521693" target="_blank">PMID:41521693</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Ablative fractional CO2 laser is effective for acne scar treatment but is often associated with side effects such as erythema and dyspigmentation, along with prolonged recovery time."</div>
                
                
                <div class="evidence-explanation">This trial background notes efficacy of CO2 laser for acne scars with notable side effects.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Post-laser antioxidant serum
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Topical antioxidant serum with vitamins C and E (with ferulic acid) is used after ablative laser procedures to support skin recovery.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41521693" target="_blank">PMID:41521693</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This study found that CE Ferulic led to enhanced wound healing, reduced erythema and melanin levels, and improved skin hydration following laser treatment, suggesting its beneficial application in combination with laser treatment to accelerate skin recovery."</div>
                
                
                <div class="evidence-explanation">This split-face trial supports antioxidant serum use after CO2 laser for acne scars.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Blue light therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000014" target="_blank">
                            MAXO:0000014
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Blue light phototherapy is used as an alternative for inflammatory acne, with evidence of clinical improvement.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/34696155" target="_blank">PMID:34696155</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Studies have shown significant improvements in the overall picture of acne."</div>
                
                
                <div class="evidence-explanation">This systematic review reports clinical improvement in acne with blue light phototherapy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Visible light therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000014" target="_blank">
                            MAXO:0000014
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Visible light devices, including blue light, can reduce acne lesion counts in patients seeking nonpharmacologic treatments.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39056372" target="_blank">PMID:39056372</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Overall, 92% of patients achieved partial remission of their acne lesions using visible light therapy."</div>
                
                
                <div class="evidence-explanation">This systematic review summarizes lesion improvement across visible light studies in acne.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Photodynamic therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000014" target="_blank">
                            MAXO:0000014
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Photodynamic therapy is used off-label for inflammatory acne with evidence supporting efficacy in dermatologic indications.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39226531" target="_blank">PMID:39226531</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Newer indications, for which no approval has yet been granted, but which nevertheless have sufficient evidence of efficacy according to the study situation, are inflammatory (lichen sclerosus, acne) and infectious dermatoses (viral warts, cutaneous leishmaniasis, atypical mycobacteriosis)."</div>
                
                
                <div class="evidence-explanation">This review identifies acne as an emerging indication for photodynamic therapy with supportive evidence.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Nd:YAG laser and intralesional PRP
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001417" target="_blank">
                            MAXO:0001417
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Nd:YAG laser and intralesional platelet-rich plasma injections are used for inflammatory acne in split-face comparative protocols.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/35084634" target="_blank">PMID:35084634</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The intralesional PRP injection and 1064 nm long-pulsed Nd:YAG laser are safe and effective methods for controlling inflammatory as well as non-inflammatory acne vulgaris in both adolescents and post-adolescent patients."</div>
                
                
                <div class="evidence-explanation">This randomized split-face study supports Nd:YAG laser and PRP injections for inflammatory acne vulgaris.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    1726 nm laser therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0001578" target="_blank">
                            MAXO:0001578
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Targeted laser therapy that selectively affects sebaceous glands and is being evaluated for moderate to severe acne.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38271552" target="_blank">PMID:38271552</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"New 1726 nm lasers specifically target the sebaceous gland, which is known to be pivotal in acne pathophysiology."</div>
                
                
                <div class="evidence-explanation">This review highlights 1726 nm lasers as a sebaceous gland-targeted treatment approach for acne.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Diet</div>
                
                
                <div class="item-desc">High glycemic index foods and dairy products have been associated with acne severity, possibly through effects on insulin/IGF-1 signaling and hormonal modulation.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32748305" target="_blank">PMID:32748305</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Several studies have evaluated the significance of the glycemic index of various foods and glycemic load in patients with acne, demonstrating individuals with acne who consume diets with a low glycemic load have reduced acne lesions compared with individuals on high glycemic load diets."</div>
                
                
                <div class="evidence-explanation">This review provides evidence for the association between high glycemic load diets and acne severity.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32748305" target="_blank">PMID:32748305</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Dairy has also been a focus of study regarding dietary influences on acne; whey proteins responsible for the insulinotropic effects of milk may contribute more to acne development than the actual fat or dairy content."</div>
                
                
                <div class="evidence-explanation">The paper describes the mechanism by which dairy consumption may influence acne through insulinotropic effects.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Stress</div>
                
                
                <div class="item-desc">Psychological stress can exacerbate acne through effects on the hypothalamic-pituitary-adrenal axis and increased sebum production.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28871928" target="_blank">PMID:28871928</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Even though emotional stress has long been suspected to trigger or exacerbate acne, its influence on acne severity has been mostly underestimated until recently when studies have brought new data about the different mechanisms and possible factors involved in this interaction."</div>
                
                
                <div class="evidence-explanation">This review examines the link between psychological stress and acne exacerbation.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/28871928" target="_blank">PMID:28871928</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The basis for the association between emotional stress and the onset or exacerbation of acne is in several cutaneous neurogenic factors which interact with a pathogenic cascade in acne."</div>
                
                
                <div class="evidence-explanation">The paper describes neurogenic mechanisms linking stress to acne pathogenesis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Air pollution and climate stressors</div>
                
                
                <div class="item-desc">Repeated exposure to rising pollutant levels and climate-related environmental changes is associated with acne burden.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41464454" target="_blank">PMID:41464454</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Psoriasis, acne vulgaris, atopic dermatitis, photoaging, melasma, and skin cancers have been associated with repeated exposure to rising levels of pollutants."</div>
                
                
                <div class="evidence-explanation">This review links acne vulgaris with pollutant exposure among climate-sensitive skin conditions.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Androgens
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/32748305" target="_blank">PMID:32748305</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Excess sebum production occurs because of increased activity of androgen hormones and IGF-1"</div>
                
                
                <div class="evidence-explanation">This paper directly links androgen hormones to excess sebum production in acne pathogenesis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Sebum lipids
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Altered)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20871834" target="_blank">PMID:20871834</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Altered ratio between saturated and unsaturated fatty acids has been indicated as an important feature to be considered in addition to the altered amount of specific fatty acids such as linoleic acid"</div>
                
                
                <div class="evidence-explanation">This review describes alterations in sebum fatty acid composition as a key feature in acne pathogenesis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    IL-17
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41465543" target="_blank">PMID:41465543</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Serum IL-17 levels were significantly higher in the control group compared to both acne groups (p &lt; 0.05), with no gender-related differences."</div>
                
                
                <div class="evidence-explanation">This study reports decreased serum IL-17 in acne vulgaris compared with controls.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        
        <div class="card" id="differentials">
            <div class="card-header">
                <div class="card-icon" style="background: #fef2f2; color: #dc2626;">🔀</div>
                <h2 class="card-title">Differential Diagnoses</h2>
                <span class="card-count">3</span>
            </div>
            <p style="margin-bottom: 16px; font-size: 0.95rem; color: var(--text-muted);">
                Conditions with similar clinical presentations that must be differentiated from Acne Vulgaris:
            </p>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    PAPASH syndrome
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0958343" target="_blank">
                            MONDO:0958343
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Autoinflammatory syndrome combining acne with pyoderma gangrenosum, hidradenitis suppurativa, and inflammatory arthritis.

                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Syndromic triad with pyoderma gangrenosum and hidradenitis suppurativa alongside acne.</li>
                        
                        <li>Systemic inflammatory arthritis or other autoinflammatory features.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41499625" target="_blank">PMID:41499625</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"PAPASH spectrum syndrome is a rare autoinflammatory condition encompassing psoriatic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa."</div>
                
                
                <div class="evidence-explanation">This case report defines PAPASH syndrome as a syndromic condition including acne and related inflammatory diseases.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Rosacea
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0006604" target="_blank">
                            MONDO:0006604
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Chronic inflammatory facial dermatosis with papules and pustules but no comedones. Central facial erythema, flushing, and telangiectasias can mimic inflammatory acne on the face.

                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Absence of comedones with prominent centrofacial erythema and telangiectasias.</li>
                        
                        <li>Burning or stinging with triggers such as heat, alcohol, or spicy foods rather than androgen-driven distribution.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12113648" target="_blank">PMID:12113648</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Localized pustular eruptions are seen on the hands and feet in adults with pustulosis palmaris et plantaris and acrodermatitis continua (both of which may be variants of psoriasis); on the face in patients with acne vulgaris, rosacea, and perioral dermatitis; and on the trunk and/or extremities..."</div>
                
                
                <div class="evidence-explanation">The abstract lists rosacea alongside acne as a facial pustular eruption, underscoring the need for clinical differentiation.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Bacterial folliculitis
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0006552" target="_blank">
                            MONDO:0006552
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Infection or inflammation of hair follicles producing papules and pustules on hair-bearing skin, often the trunk or extremities, that can resemble acne lesions but lacks comedones and is frequently pruritic.

                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Lesions centered on hair follicles without open or closed comedones; often pruritic and may follow shaving or occlusion.</li>
                        
                        <li>Distribution favors trunk, buttocks, and extremities rather than the typical facial and truncal comedones of acne.</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/12113648" target="_blank">PMID:12113648</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Localized pustular eruptions are seen on the hands and feet in adults with pustulosis palmaris et plantaris and acrodermatitis continua (both of which may be variants of psoriasis); on the face in patients with acne vulgaris, rosacea, and perioral dermatitis; and on the trunk and/or extremities..."</div>
                
                
                <div class="evidence-explanation">The abstract notes folliculitis presents with pustular eruptions on the trunk or extremities, highlighting its overlap with acneiform lesions.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Datasets -->
        
        <div class="card" id="datasets">
            <div class="card-header">
                <div class="card-icon" style="background: #e0f2fe; color: #0284c7;">📊</div>
                <h2 class="card-title">Related Datasets</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Microbiome-Derived Indole-3-lactic Acid Attenuates Cutibacterium acnes-Induced Inflammation via the Aryl Hydrocarbon Receptor Pathway
                    
                    <span class="dataset-accession">
                        <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315350" target="_blank">geo:GSE315350</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Transcriptomic profiling of C. acnes-driven inflammation with microbiome- derived tryptophan metabolites highlighting AHR pathway modulation.</div>
                
                <div class="item-meta">
                    
                    
                    
                    
                </div>
                
                
                
                
    
    
                
                
                <div class="item-desc" style="margin-top: 8px; font-style: italic;">Summary describes human keratinocyte stimulation and a C. acnes mouse model.</div>
                
                
    
    
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Spatial transcriptomics reveals dysfunctional lipid metabolism and abnormal pilosebaceous differentiation in acne vulgaris
                    
                    <span class="dataset-accession">
                        <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301280" target="_blank">geo:GSE301280</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Spatial transcriptomics of healthy, non-lesional, comedonal, and pustular acne skin using a panel targeting sebaceous differentiation, lipid metabolism, and retinoid signaling.</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">human</span>
                    
                    
                    <span class="tag tag-datatype">SPATIAL TRANSCRIPTOMICS</span>
                    
                    
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0369a1;">Conditions:</strong>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">healthy skin</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">non-lesional acne skin</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">comedonal acne skin</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">pustular acne skin</span>
                    
                </div>
                
                
                
    
    
                
                
                <div class="item-desc" style="margin-top: 8px; font-style: italic;">Identifies altered sebogenesis and retinoid signaling across lesion types.</div>
                
                
    
    
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    High-Resolution Spatial Map of the Human Facial Sebaceous Gland Reveals Marker Genes and Decodes Sebocyte Differentiation [MERFISH]
                    
                    <span class="dataset-accession">
                        <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292394" target="_blank">geo:GSE292394</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Spatial transcriptomics and MERFISH profiling of human facial sebaceous glands to map sebocyte differentiation stages.</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">human</span>
                    
                    
                    <span class="tag tag-datatype">SPATIAL TRANSCRIPTOMICS</span>
                    
                    
                    
                </div>
                
                
                
                
    
    
                
                
                <div class="item-desc" style="margin-top: 8px; font-style: italic;">Integrates spatial transcriptomics with single-cell profiling of sebaceous glands.</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Clinical Trials -->
        
        <div class="card" id="trials">
            <div class="card-header">
                <div class="card-icon" style="background: #f5f3ff; color: #a855f7;">🔬</div>
                <h2 class="card-title">Clinical Trials</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT00421993
                    
                    <span class="tag tag-phase">PHASE_III</span>
                    
                    
                    <span class="tag tag-status">COMPLETED</span>
                    
                </div>
                
                <div class="item-desc">Multicenter, randomized, double-blind trial comparing adapalene/benzoyl peroxide gel with monotherapies and vehicle in acne vulgaris over 12 weeks.</div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        comedonal acne
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0040137" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        erythematous papule
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0030350" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        pustule
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0200039" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT00421993" target="_blank">clinicaltrials:NCT00421993</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"This is a multi-center, randomized, double-blind, parallel group study with 12 weeks of treatment of acne vulgaris."</div>
                
                
                <div class="evidence-explanation">The trial evaluates a combination topical therapy specifically in participants with acne vulgaris.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box clinical-trial-box">
                <div class="item-name">
                    NCT02249767
                    
                    <span class="tag tag-phase">PHASE_III</span>
                    
                    
                    <span class="tag tag-status">COMPLETED</span>
                    
                </div>
                
                <div class="item-desc">Double-blind, randomized, parallel-group study assessing tretinoin gel bioequivalence in patients with mild acne vulgaris.</div>
                
                
                <div class="item-meta">
                    <strong style="font-size: 0.8rem; color: #6b21a8;">Target Phenotypes:</strong>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        comedonal acne
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0040137" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag" style="background: #ede9fe; color: #6b21a8; font-size: 0.8rem;">
                        erythematous papule
                        
                        <a href="http://purl.obolibrary.org/obo/HP_0030350" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://clinicaltrials.gov/study/NCT02249767" target="_blank">clinicaltrials:NCT02249767</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Normal, healthy male and female children and adults (i.e., ages 12 to 40 years) with at least Grade 2 (i.e., mild severity) acne vulgaris were treated on the full face once daily for 84 days with the Tretinoin Gel 0.05%, Brand (tretinoin) Gel 0.05%, or Gel Vehicle."</div>
                
                
                <div class="evidence-explanation">This study explicitly enrolls participants with acne vulgaris and evaluates topical tretinoin treatment.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Acne Vulgaris
category: Complex
disease_term:
  preferred_term: acne vulgaris
  term:
    id: MONDO:0011438
    label: acne
parents:
  - Inflammatory skin disease
  - Pilosebaceous unit disorder
infectious_agent:
  - name: Cutibacterium acnes
    infectious_agent_term:
      preferred_term: Cutibacterium acnes
      term:
        id: NCBITaxon:1747
        label: Cutibacterium acnes
    description: Commensal skin bacterium that proliferates in occluded follicles and contributes to inflammatory acne lesions.
    evidence:
      - reference: PMID:24062871
        supports: SUPPORT
        snippet: &#34;Propionibacterium acnes colonizes the duct of the sebaceous follicle, causing an innate immune response and the progression from a so-called noninflammatory comedo to an inflammatory papule, pustule, or nodule.&#34;
        explanation: This review links C. acnes colonization to inflammatory progression in acne.
prevalence:
  - population: Adolescents and young adults (Europe, ages 15-24 years)
    percentage: 57.8
    evidence:
      - reference: PMID:28707712
        supports: SUPPORT
        snippet: &#34;The overall adjusted prevalence of self-reported acne was 57.8% (95% confidence interval 56.9% to 58.7%).&#34;
        explanation: This European survey reports a high prevalence of acne among adolescents and young adults.
  - population: Adolescents and young adults (global, ages 10-24 years, 2021)
    percentage: 9.79
    evidence:
      - reference: PMID:39271178
        supports: SUPPORT
        snippet: |-
          RESULTS: Globally, the age-standardized prevalence rate of acne vulgaris among 
          adolescents and young adults increased from 8563.4 per 100 000 population [95% 
          uncertainty interval (UI) 7343.5-9920.1] in 1990 to 9790.5 (95% UI 8420.9-11 
          287.2) per 100 000 population in 2021, with an AAPC of 0.43 [95% confidence 
          interval (CI) 0.41-0.46].
        explanation: The 2021 age-standardized prevalence of 9790.5 per 100,000 corresponds to about 9.79%.
  - population: Young people (moderate-to-severe acne)
    percentage: 20
    evidence:
      - reference: PMID:23210645
        supports: SUPPORT
        snippet: &#34;Moderate-to-severe acne affects around 20% of young people and severity correlates with pubertal maturity.&#34;
        explanation: This review summarizes the prevalence of moderate-to-severe acne among young people.
pathophysiology:
  - name: Follicular keratinization
    description: &gt;
      Dysregulated keratinocyte differentiation and desquamation within the
      follicular epithelium promotes retention hyperkeratosis.
    cell_types:
      - preferred_term: keratinocyte
        term:
          id: CL:0000312
          label: keratinocyte
    locations:
      - preferred_term: pilosebaceous unit
        term:
          id: UBERON:0011932
          label: pilosebaceous unit
    evidence:
      - reference: PMID:32748305
        supports: SUPPORT
        snippet: &#34;Acne pathogenesis is attributed to four key factors: excess sebum production, hyperproliferation of Cutibacterium acnes (C. acnes, formerly called Propionibacterium acnes) bacteria, hyperkeratinization of the pilosebaceous follicles, and inflammatory mechanisms&#34;
        explanation: This review explicitly identifies hyperkeratinization of the pilosebaceous follicles as a key factor in acne pathogenesis.
  - name: Microcomedone formation
    description: &gt;
      Follicular obstruction from retained keratin and sebum leads to early
      microcomedone development that seeds later visible comedones.
    cell_types:
      - preferred_term: keratinocyte
        term:
          id: CL:0000312
          label: keratinocyte
    locations:
      - preferred_term: pilosebaceous unit
        term:
          id: UBERON:0011932
          label: pilosebaceous unit
    evidence:
      - reference: PMID:32748305
        supports: SUPPORT
        snippet: &#34;Acne pathogenesis is attributed to four key factors: excess sebum production, hyperproliferation of Cutibacterium acnes (C. acnes, formerly called Propionibacterium acnes) bacteria, hyperkeratinization of the pilosebaceous follicles, and inflammatory mechanisms&#34;
        explanation: Follicular hyperkeratinization is the initiating event that drives microcomedone formation in acne.
  - name: Sebum overproduction
    description: &gt;
      Androgen and IGF-1 signaling increase sebocyte activity, elevating sebum
      output and creating a lipid-rich follicular environment.
    cell_types:
      - preferred_term: sebocyte
        term:
          id: CL:0000317
          label: sebocyte
    biological_processes:
      - preferred_term: lipid metabolism
        term:
          id: GO:0006629
          label: lipid metabolic process
    evidence:
      - reference: PMID:32748305
        supports: SUPPORT
        snippet: &#34;In acne, mTORC1 mediates sebaceous gland hyperproliferation, lipid synthesis, and hyperplasia of keratinocytes&#34;
        explanation: This review links sebaceous gland hyperproliferation and lipid synthesis to acne pathogenesis.
  - name: Sebum compositional change
    description: &gt;
      Altered fatty acid ratios and oxidation products within sebum contribute
      to comedogenesis and inflammatory signaling.
    cell_types:
      - preferred_term: sebocyte
        term:
          id: CL:0000317
          label: sebocyte
    biological_processes:
      - preferred_term: lipid metabolism
        term:
          id: GO:0006629
          label: lipid metabolic process
    evidence:
      - reference: PMID:20871834
        supports: SUPPORT
        snippet: &#34;Altered ratio between saturated and unsaturated fatty acids has been indicated as an important feature to be considered in addition to the altered amount of specific fatty acids such as linoleic acid&#34;
        explanation: This review highlights altered sebum fatty acid composition as a pathophysiologic feature of acne.
  - name: C. acnes follicular colonization
    description: &gt;
      Cutibacterium acnes expands within occluded follicles and contributes to
      lesion progression from noninflammatory comedones to inflamed papules.
    cell_types:
      - preferred_term: sebocyte
        term:
          id: CL:0000317
          label: sebocyte
    locations:
      - preferred_term: pilosebaceous unit
        term:
          id: UBERON:0011932
          label: pilosebaceous unit
    evidence:
      - reference: PMID:24062871
        supports: SUPPORT
        snippet: &#34;Propionibacterium acnes colonizes the duct of the sebaceous follicle, causing an innate immune response and the progression from a so-called noninflammatory comedo to an inflammatory papule, pustule, or nodule.&#34;
        explanation: This review describes C. acnes colonization and its role in lesion progression.
  - name: Inflammasome activation
    description: &gt;
      Innate immune sensing activates inflammasome pathways that amplify
      inflammatory signaling in acne lesions.
    cell_types:
      - preferred_term: macrophage
        term:
          id: CL:0000235
          label: macrophage
    biological_processes:
      - preferred_term: inflammatory response
        term:
          id: GO:0006954
          label: inflammatory response
    evidence:
      - reference: DOI:10.3389/fimmu.2023.1075834
        supports: SUPPORT
        snippet: &#34;The inflammasomes are intracellular multimeric protein complexes consisting of an innate immune sensor, the adapter protein ASC and the inflammatory caspases-1 and/or -11 and are important for the host defense against pathogens.&#34;
        explanation: This review explains inflammasome activation, a key mechanism implicated in acne inflammation.
  - name: Cytokine-driven inflammation
    description: &gt;
      Inflammasome and innate immune activation drive cytokine release that
      recruits neutrophils and sustains inflammatory lesion formation.
    cell_types:
      - preferred_term: neutrophil
        term:
          id: CL:0000775
          label: neutrophil
    biological_processes:
      - preferred_term: inflammatory response
        term:
          id: GO:0006954
          label: inflammatory response
    evidence:
      - reference: DOI:10.3389/fimmu.2023.1075834
        supports: SUPPORT
        snippet: &#34;The inflammasomes are intracellular multimeric protein complexes consisting of an innate immune sensor, the adapter protein ASC and the inflammatory caspases-1 and/or -11 and are important for the host defense against pathogens.&#34;
        explanation: Inflammasome activation supports downstream cytokine-mediated inflammation in acne lesions.
phenotypes:
  - name: Comedones
    description: &gt;
      Non-inflammatory lesions including open comedones (blackheads) and closed
      comedones (whiteheads) resulting from follicular plugging.
    phenotype_term:
      preferred_term: comedonal acne
      term:
        id: HP:0040137
        label: Comedonal acne
    evidence:
      - reference: PMID:24062871
        supports: SUPPORT
        snippet: &#34;evidence has emerged supporting a role for inflammation at all stages of acne lesion development, perhaps subclinically even before comedo formation&#34;
        explanation: This review discusses the role of comedones as a key lesion type in acne pathogenesis.
  - name: Inflammatory papules
    description: &gt;
      Small, raised, erythematous lesions resulting from inflammation around
      occluded follicles.
    phenotype_term:
      preferred_term: erythematous papule
      term:
        id: HP:0030350
        label: Erythematous papule
    evidence:
      - reference: PMID:24062871
        supports: SUPPORT
        snippet: &#34;the progression from a so-called noninflammatory comedo to an inflammatory papule, pustule, or nodule&#34;
        explanation: This review describes the progression from comedones to inflammatory papules in acne lesion development.
  - name: Pustules
    description: &gt;
      Inflamed lesions containing purulent material, representing more advanced
      inflammatory response.
    phenotype_term:
      preferred_term: pustule
      term:
        id: HP:0200039
        label: Pustule
    evidence:
      - reference: PMID:12113648
        supports: SUPPORT
        snippet: &#34;Localized pustular eruptions are seen on the hands and feet in adults with pustulosis palmaris et plantaris and acrodermatitis continua (both of which may be variants of psoriasis); on the face in patients with acne vulgaris, rosacea, and perioral dermatitis&#34;
        explanation: This review identifies pustular eruptions on the face as a characteristic feature of acne vulgaris.
  - name: Nodules and cysts
    description: &gt;
      Deep, painful lesions representing severe inflammatory acne with potential
      for scarring.
    phenotype_term:
      preferred_term: cystic acne
      term:
        id: HP:0033188
        label: Cystic acne
    evidence:
      - reference: PMID:21062102
        supports: SUPPORT
        snippet: &#34;Severe nodular acne, defined as grade 4 or 5 acne on the Investigator&#39;s Static Global Assessment scale, is a skin condition characterized by intense erythema, inflammation, nodules, cysts, and scarring.&#34;
        explanation: This review defines severe nodular acne as characterized by nodules and cysts with associated inflammation and scarring potential.
  - name: Post-inflammatory hyperpigmentation
    description: &gt;
      Darkening of skin at sites of resolved acne lesions, particularly common
      in individuals with darker skin tones. This sequela results from inflammatory
      damage to melanocytes and is a common concern in patients with skin of color.
    phenotype_term:
      preferred_term: hyperpigmentation of the skin
      term:
        id: HP:0000953
        label: Hyperpigmentation of the skin
    evidence:
      - reference: PMID:34468934
        supports: SUPPORT
        snippet: &#34;the inflammatory processes of acne stimulate excess melanogenesis and abnormal melanin deposition, leading to pigmentary sequelae known as post-inflammatory hyperpigmentation&#34;
        explanation: This paper specifically describes the pathogenesis of acne-induced post-inflammatory hyperpigmentation through excess melanin production.
  - name: Scarring
    description: &gt;
      Permanent textural changes including atrophic (ice pick, boxcar, rolling)
      and hypertrophic scars resulting from severe or inadequately treated acne.
    phenotype_term:
      preferred_term: atrophic scars
      term:
        id: HP:0001075
        label: Atrophic scars
    evidence:
      - reference: PMID:29344322
        supports: SUPPORT
        snippet: &#34;This review focuses on atrophic scars, the most common type of acne scar.&#34;
        explanation: This review confirms atrophic scars as the most common type of acne scarring.
biochemical:
  - name: Androgens
    presence: Elevated
    notes: &gt;
      Androgens (testosterone, DHT) stimulate sebaceous gland activity through
      androgen receptor signaling, explaining the onset of acne at puberty and
      its association with hyperandrogenic states.
    evidence:
      - reference: PMID:32748305
        supports: SUPPORT
        snippet: &#34;Excess sebum production occurs because of increased activity of androgen hormones and IGF-1&#34;
        explanation: This paper directly links androgen hormones to excess sebum production in acne pathogenesis.
  - name: Sebum lipids
    presence: Altered
    notes: &gt;
      Changes in sebum composition, including altered fatty acid profiles and
      increased squalene oxidation, contribute to comedogenesis and inflammation.
    evidence:
      - reference: PMID:20871834
        supports: SUPPORT
        snippet: &#34;Altered ratio between saturated and unsaturated fatty acids has been indicated as an important feature to be considered in addition to the altered amount of specific fatty acids such as linoleic acid&#34;
        explanation: This review describes alterations in sebum fatty acid composition as a key feature in acne pathogenesis.
  - name: IL-17
    presence: Decreased
    notes: &gt;
      Serum IL-17 levels are lower in acne vulgaris compared with controls in a
      severity-stratified cohort, suggesting altered systemic cytokine signaling.
    evidence:
      - reference: PMID:41465543
        supports: SUPPORT
        snippet: &#34;Serum IL-17 levels were significantly higher in the control group compared to both acne groups (p &lt; 0.05), with no gender-related differences.&#34;
        explanation: This study reports decreased serum IL-17 in acne vulgaris compared with controls.
genetic:
  - name: Polygenic susceptibility
    association: Associated
    notes: &gt;
      Twin studies demonstrate high heritability. Multiple genetic variants
      affecting androgen metabolism, inflammatory pathways, and sebaceous gland
      function contribute to acne susceptibility.
    evidence:
      - reference: PMID:32748305
        supports: SUPPORT
        snippet: &#34;It is known that multiple factors impact acne pathophysiology, including genetic, hormonal, inflammatory, and environmental influences.&#34;
        explanation: This review explicitly identifies genetic factors as one of the key influences on acne pathophysiology.
      - reference: PMID:40689430
        supports: SUPPORT
        snippet: &#34;Both GWAS and single gene disorders unequivocally indicate stem/progenitor cell maintenance and cellular migration as the most important processes in the pathogenesis of acne.&#34;
        explanation: This genetics review connects GWAS and monogenic findings to core biological processes underlying acne susceptibility.
  - name: Candidate gene families
    association: Associated
    notes: &gt;
      Reviews highlight inflammatory cytokine genes (IL, TNF), RETN, CYP family
      genes, and extracellular matrix regulators (MMPs, TIMPs) as recurrent
      candidates linked to acne susceptibility.
    evidence:
      - reference: PMID:37662507
        supports: SUPPORT
        snippet: &#34;some genes (such as IL, TNF, RETN, CYP family, MMPs and TIMPs genes et al) are associated with acne vulgaris and may affect the progression and prognosis of the disease.&#34;
        explanation: This review summarizes multiple gene families repeatedly implicated in acne susceptibility and outcomes.
  - name: RETN-420C&gt;G and IL6-572G&gt;C polymorphisms
    association: Associated
    notes: &gt;
      Case-control data in a Chinese cohort link RETN-420G and IL6-572C alleles
      to increased acne susceptibility and severity.
    evidence:
      - reference: PMID:35279931
        supports: SUPPORT
        snippet: &#34;There is a strong correlation between RETN-420 and IL6-572 polymorphisms and acne susceptibility; the RETN-420G and IL6-572C alleles increase the risk of acne development.&#34;
        explanation: This study reports RETN-420 and IL6-572 risk alleles associated with acne susceptibility.
  - name: TNFR2 M196R and TLR2 Arg753Gln polymorphisms
    association: Associated
    notes: &gt;
      Risk alleles in TNFR2 and TLR2 are enriched in moderate-to-severe acne
      subgroups, supporting an inflammatory genetic contribution.
    evidence:
      - reference: PMID:20861605
        supports: SUPPORT
        snippet: &#34;The 196R allele of TNFR2 M196R as well as the 753Gln allele of TLR2 Arg753Gln are risk factors for acne vulgaris in Chinese Han patients, further supporting the contribution of inflammatory cytokines to the pathogenesis of acne.&#34;
        explanation: This study links TNFR2 and TLR2 risk alleles to acne susceptibility in a Chinese Han cohort.
environmental:
  - name: Diet
    description: &gt;
      High glycemic index foods and dairy products have been associated with
      acne severity, possibly through effects on insulin/IGF-1 signaling and
      hormonal modulation.
    evidence:
      - reference: PMID:32748305
        supports: SUPPORT
        snippet: &#34;Several studies have evaluated the significance of the glycemic index of various foods and glycemic load in patients with acne, demonstrating individuals with acne who consume diets with a low glycemic load have reduced acne lesions compared with individuals on high glycemic load diets.&#34;
        explanation: This review provides evidence for the association between high glycemic load diets and acne severity.
      - reference: PMID:32748305
        supports: SUPPORT
        snippet: &#34;Dairy has also been a focus of study regarding dietary influences on acne; whey proteins responsible for the insulinotropic effects of milk may contribute more to acne development than the actual fat or dairy content.&#34;
        explanation: The paper describes the mechanism by which dairy consumption may influence acne through insulinotropic effects.
  - name: Stress
    description: &gt;
      Psychological stress can exacerbate acne through effects on the
      hypothalamic-pituitary-adrenal axis and increased sebum production.
    evidence:
      - reference: PMID:28871928
        supports: SUPPORT
        snippet: &#34;Even though emotional stress has long been suspected to trigger or exacerbate acne, its influence on acne severity has been mostly underestimated until recently when studies have brought new data about the different mechanisms and possible factors involved in this interaction.&#34;
        explanation: This review examines the link between psychological stress and acne exacerbation.
      - reference: PMID:28871928
        supports: SUPPORT
        snippet: &#34;The basis for the association between emotional stress and the onset or exacerbation of acne is in several cutaneous neurogenic factors which interact with a pathogenic cascade in acne.&#34;
        explanation: The paper describes neurogenic mechanisms linking stress to acne pathogenesis.
  - name: Air pollution and climate stressors
    description: &gt;
      Repeated exposure to rising pollutant levels and climate-related
      environmental changes is associated with acne burden.
    evidence:
      - reference: PMID:41464454
        supports: SUPPORT
        snippet: &#34;Psoriasis, acne vulgaris, atopic dermatitis, photoaging, melasma, and skin cancers have been associated with repeated exposure to rising levels of pollutants.&#34;
        explanation: This review links acne vulgaris with pollutant exposure among climate-sensitive skin conditions.

datasets:
  - accession: geo:GSE315350
    title: Microbiome-Derived Indole-3-lactic Acid Attenuates Cutibacterium acnes-Induced Inflammation via the Aryl Hydrocarbon Receptor Pathway
    description: &gt;-
      Transcriptomic profiling of C. acnes-driven inflammation with microbiome-
      derived tryptophan metabolites highlighting AHR pathway modulation.
    notes: Summary describes human keratinocyte stimulation and a C. acnes mouse model.
  - accession: geo:GSE301280
    title: Spatial transcriptomics reveals dysfunctional lipid metabolism and abnormal pilosebaceous differentiation in acne vulgaris
    description: &gt;-
      Spatial transcriptomics of healthy, non-lesional, comedonal, and pustular
      acne skin using a panel targeting sebaceous differentiation, lipid
      metabolism, and retinoid signaling.
    organism:
      preferred_term: human
      term:
        id: NCBITaxon:9606
        label: Homo sapiens
    data_type: SPATIAL_TRANSCRIPTOMICS
    conditions:
      - healthy skin
      - non-lesional acne skin
      - comedonal acne skin
      - pustular acne skin
    notes: Identifies altered sebogenesis and retinoid signaling across lesion types.
  - accession: geo:GSE292394
    title: High-Resolution Spatial Map of the Human Facial Sebaceous Gland Reveals Marker Genes and Decodes Sebocyte Differentiation [MERFISH]
    description: &gt;-
      Spatial transcriptomics and MERFISH profiling of human facial sebaceous
      glands to map sebocyte differentiation stages.
    organism:
      preferred_term: human
      term:
        id: NCBITaxon:9606
        label: Homo sapiens
    data_type: SPATIAL_TRANSCRIPTOMICS
    notes: Integrates spatial transcriptomics with single-cell profiling of sebaceous glands.

treatments:
  - name: Topical retinoids
    description: &gt;
      First-line treatment that normalizes follicular keratinization, reduces
      comedone formation, and has anti-inflammatory effects. Examples include
      tretinoin, adapalene, and tazarotene.
    treatment_term:
      preferred_term: retinoid agent therapy
      term:
        id: MAXO:0000237
        label: retinoid agent therapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: retinoid
            term:
              id: NCIT:C68299
              label: Retinoid
    evidence:
      - reference: PMID:30674002
        supports: SUPPORT
        snippet: &#34;Topical retinoids are safe and efficacious for the treatment of acne vulgaris.&#34;
        explanation: This systematic review confirms the safety and efficacy of topical retinoids for acne treatment.
  - name: Trifarotene
    description: &gt;
      Topical retinoid selective for retinoic acid receptor gamma with evidence
      for reducing comedonal and inflammatory lesions, including truncal acne.
    treatment_term:
      preferred_term: retinoid agent therapy
      term:
        id: MAXO:0000237
        label: retinoid agent therapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: trifarotene
            term:
              id: NCIT:C118577
              label: Trifarotene
    evidence:
      - reference: PMID:36927117
        supports: SUPPORT
        snippet: &#34;Large-scale randomized, controlled clinical trials have demonstrated trifarotene to be safe, well tolerated, and efficacious in reducing both comedones and papules/pustules of acne.&#34;
        explanation: This review summarizes randomized trials showing trifarotene efficacy across comedonal and inflammatory acne lesions.
  - name: Benzoyl peroxide
    description: &gt;
      Antimicrobial agent that kills C. acnes through oxidative damage without
      promoting antibiotic resistance. Also has mild comedolytic activity.
    treatment_term:
      preferred_term: antimicrobial agent therapy
      term:
        id: MAXO:0001021
        label: antimicrobial agent therapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: benzoyl peroxide
            term:
              id: NCIT:C47411
              label: Benzoyl Peroxide
    evidence:
      - reference: PMID:19761357
        supports: SUPPORT
        snippet: &#34;BPO-containing combinations do not induce bacterial resistance and are important first-line treatments for mild to moderate acne vulgaris.&#34;
        explanation: This review establishes benzoyl peroxide as an important first-line treatment for acne that does not promote bacterial resistance.
  - name: Topical antibiotics
    description: &gt;
      Clindamycin and erythromycin reduce C. acnes populations and have
      anti-inflammatory effects. Should be combined with benzoyl peroxide to
      prevent resistance.
    treatment_term:
      preferred_term: antibacterial agent therapy
      term:
        id: MAXO:0000061
        label: antibacterial agent therapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: antibiotic
            term:
              id: NCIT:C258
              label: Antibiotic
    evidence:
      - reference: PMID:16086756
        supports: SUPPORT
        snippet: &#34;topical antibiotics remain one of the cornerstones of acne management&#34;
        explanation: This systematic review confirms topical antibiotics as a cornerstone treatment for acne.
  - name: Clindamycin/adapalene/benzoyl peroxide gel
    description: &gt;
      Triple-combination topical therapy for moderate to severe acne, combining
      clindamycin phosphate, adapalene, and benzoyl peroxide for long-term use.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: clindamycin phosphate
            term:
              id: NCIT:C47978
              label: Clindamycin Phosphate
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: adapalene
            term:
              id: NCIT:C28989
              label: Adapalene
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: benzoyl peroxide
            term:
              id: NCIT:C47411
              label: Benzoyl Peroxide
    evidence:
      - reference: PMID:41552868
        supports: SUPPORT
        snippet: &#34;At week 24, 67% of participants achieved treatment success, and significant reductions from baseline in inflammatory (88%) and noninflammatory (68%) lesions were observed (p &lt; 0.001, both).&#34;
        explanation: This pooled analysis supports long-term efficacy of the triple-combination gel.
  - name: Oral antibiotics
    description: &gt;
      Tetracyclines (doxycycline, minocycline) are used for moderate-to-severe
      inflammatory acne. Have both antimicrobial and anti-inflammatory effects,
      but prolonged use contributes to antimicrobial resistance and requires
      stewardship.
    treatment_term:
      preferred_term: antibacterial agent therapy
      term:
        id: MAXO:0000061
        label: antibacterial agent therapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: tetracycline antibiotic
            term:
              id: NCIT:C1595
              label: Tetracycline Antibiotic
    evidence:
      - reference: PMID:28542914
        supports: SUPPORT
        snippet: &#34;isotretinoin therapy reduced acne lesion counts by a clinically relevant amount, and always by a greater amount than control, which was either placebo (two studies), oral antibiotics (seven studies) or other control&#34;
        explanation: This systematic review confirms oral antibiotics as an established comparator treatment for acne in clinical trials.
      - reference: PMID:36568833
        supports: SUPPORT
        snippet: &#34;The overuse of topical and/or systemic antibiotics, the long treatment courses used for acne, and the availability of over-the-counter antibiotic preparations, have led to the worldwide emergence of resistant strains in acne patients.&#34;
        explanation: This review documents antibiotic resistance concerns tied to prolonged acne antibiotic use, supporting stewardship in treatment.
  - name: Oral isotretinoin
    description: &gt;
      Systemic retinoid reserved for severe, recalcitrant acne. Addresses all
      four pathogenic factors but requires careful monitoring due to
      teratogenicity and other adverse effects.
    treatment_term:
      preferred_term: retinoid agent therapy
      term:
        id: MAXO:0000237
        label: retinoid agent therapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: isotretinoin
            term:
              id: NCIT:C603
              label: Isotretinoin
    evidence:
      - reference: PMID:33085149
        supports: SUPPORT
        snippet: &#34;Oral isotretinoin is the most effective treatment for moderate to severe acne and its side effects are mostly dose-dependent.&#34;
        explanation: This systematic review confirms oral isotretinoin as the most effective treatment for moderate to severe acne.
  - name: Hormonal therapy
    description: &gt;
      Combined oral contraceptives and spironolactone reduce androgen effects
      on sebaceous glands. Used in female patients with hormonal acne patterns.
    treatment_term:
      preferred_term: hormone modifying therapy
      term:
        id: MAXO:0000283
        label: hormone modifying therapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: oral contraceptive
            term:
              id: NCIT:C389
              label: Oral Contraceptive
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: spironolactone
            term:
              id: NCIT:C840
              label: Spironolactone
    evidence:
      - reference: PMID:28492054
        supports: SUPPORT
        snippet: &#34;Hormone-based therapies including combined oral contraceptive medications and spironolactone are considered effective therapies to treat adult acne in women.&#34;
        explanation: This systematic review confirms the efficacy of hormonal therapies including oral contraceptives and spironolactone for treating acne in women.
  - name: Chemical peels
    description: &gt;
      Organic acid-based peels are used to exfoliate acne-prone skin and reduce
      lesion counts, with agent selection tailored to patient tolerability.
    treatment_term:
      preferred_term: therapeutic procedure of skin of body
      term:
        id: MAXO:0001417
        label: therapeutic procedure of skin of body
      qualifiers:
        - predicate:
            preferred_term: therapeutic procedure
            term:
              id: NCIT:C49236
              label: Therapeutic Procedure
          value:
            preferred_term: chemical peel
            term:
              id: NCIT:C93203
              label: Chemical Peel
    evidence:
      - reference: PMID:37894698
        supports: SUPPORT
        snippet: &#34;The findings of this comprehensive bibliographic review indicate that organic acid-based chemical peels represent effective and safe treatment options for individuals with acne-prone skin.&#34;
        explanation: This review supports organic acid chemical peels as effective and safe adjuncts for acne-prone skin.
  - name: Azelaic acid peel
    description: &gt;
      Azelaic acid peels reduce sebum and lesion burden as a nonpharmacologic
      option for facial acne.
    treatment_term:
      preferred_term: therapeutic procedure of skin of body
      term:
        id: MAXO:0001417
        label: therapeutic procedure of skin of body
      qualifiers:
        - predicate:
            preferred_term: therapeutic procedure
            term:
              id: NCIT:C49236
              label: Therapeutic Procedure
          value:
            preferred_term: chemical peel
            term:
              id: NCIT:C93203
              label: Chemical Peel
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: azelaic acid
            term:
              id: NCIT:C47407
              label: Azelaic Acid
    evidence:
      - reference: PMID:31455112
        supports: SUPPORT
        snippet: &#34;Peels with 30% AZA reduced acne lesions and normalized the activity of the sebaceous glands.&#34;
        explanation: This study reports acne lesion reduction and sebum normalization with 30% azelaic acid peels.
  - name: Chemical peels for acne scarring
    description: &gt;
      Medium-depth peels such as glycolic acid and trichloroacetic acid are
      used to improve atrophic acne scars.
    treatment_term:
      preferred_term: therapeutic procedure of skin of body
      term:
        id: MAXO:0001417
        label: therapeutic procedure of skin of body
      qualifiers:
        - predicate:
            preferred_term: therapeutic procedure
            term:
              id: NCIT:C49236
              label: Therapeutic Procedure
          value:
            preferred_term: chemical peel
            term:
              id: NCIT:C93203
              label: Chemical Peel
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: glycolic acid
            term:
              id: NCIT:C83737
              label: Glycolic Acid
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: topical trichloroacetic acid
            term:
              id: NCIT:C125002
              label: Topical Trichloroacetic Acid
    evidence:
      - reference: PMID:39483653
        supports: SUPPORT
        snippet: &#34;A 30% TCA peel is efficacious and well-tolerated for mild-to-moderate acne scars.&#34;
        explanation: This split-face study supports TCA peels for improving acne scarring.
  - name: Ablative fractional CO2 laser
    description: &gt;
      Ablative fractional CO2 laser is used for atrophic acne scars but can
      cause erythema, dyspigmentation, and prolonged recovery.
    treatment_term:
      preferred_term: laser surgical procedure
      term:
        id: MAXO:0001578
        label: laser surgical procedure
      qualifiers:
        - predicate:
            preferred_term: therapeutic procedure
            term:
              id: NCIT:C49236
              label: Therapeutic Procedure
          value:
            preferred_term: laser therapy
            term:
              id: NCIT:C15466
              label: Laser Therapy
    evidence:
      - reference: PMID:41521693
        supports: SUPPORT
        snippet: &#34;Ablative fractional CO2 laser is effective for acne scar treatment but is often associated with side effects such as erythema and dyspigmentation, along with prolonged recovery time.&#34;
        explanation: This trial background notes efficacy of CO2 laser for acne scars with notable side effects.
  - name: Post-laser antioxidant serum
    description: &gt;
      Topical antioxidant serum with vitamins C and E (with ferulic acid) is
      used after ablative laser procedures to support skin recovery.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: vitamin C
            term:
              id: NCIT:C68507
              label: Vitamin C
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: topical vitamin E
            term:
              id: NCIT:C67081
              label: Topical Vitamin E
    evidence:
      - reference: PMID:41521693
        supports: SUPPORT
        snippet: &#34;This study found that CE Ferulic led to enhanced wound healing, reduced erythema and melanin levels, and improved skin hydration following laser treatment, suggesting its beneficial application in combination with laser treatment to accelerate skin recovery.&#34;
        explanation: This split-face trial supports antioxidant serum use after CO2 laser for acne scars.
  - name: Blue light therapy
    description: &gt;
      Blue light phototherapy is used as an alternative for inflammatory acne,
      with evidence of clinical improvement.
    treatment_term:
      preferred_term: radiation therapy
      term:
        id: MAXO:0000014
        label: radiation therapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic procedure
            term:
              id: NCIT:C49236
              label: Therapeutic Procedure
          value:
            preferred_term: phototherapy
            term:
              id: NCIT:C15301
              label: Phototherapy
    evidence:
      - reference: PMID:34696155
        supports: SUPPORT
        snippet: &#34;Studies have shown significant improvements in the overall picture of acne.&#34;
        explanation: This systematic review reports clinical improvement in acne with blue light phototherapy.
  - name: Visible light therapy
    description: &gt;
      Visible light devices, including blue light, can reduce acne lesion
      counts in patients seeking nonpharmacologic treatments.
    treatment_term:
      preferred_term: radiation therapy
      term:
        id: MAXO:0000014
        label: radiation therapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic procedure
            term:
              id: NCIT:C49236
              label: Therapeutic Procedure
          value:
            preferred_term: phototherapy
            term:
              id: NCIT:C15301
              label: Phototherapy
    evidence:
      - reference: PMID:39056372
        supports: SUPPORT
        snippet: &#34;Overall, 92% of patients achieved partial remission of their acne lesions using visible light therapy.&#34;
        explanation: This systematic review summarizes lesion improvement across visible light studies in acne.
  - name: Photodynamic therapy
    description: &gt;
      Photodynamic therapy is used off-label for inflammatory acne with
      evidence supporting efficacy in dermatologic indications.
    treatment_term:
      preferred_term: radiation therapy
      term:
        id: MAXO:0000014
        label: radiation therapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic procedure
            term:
              id: NCIT:C49236
              label: Therapeutic Procedure
          value:
            preferred_term: photodynamic therapy
            term:
              id: NCIT:C15300
              label: Photodynamic Therapy
    evidence:
      - reference: PMID:39226531
        supports: SUPPORT
        snippet: &#34;Newer indications, for which no approval has yet been granted, but which nevertheless have sufficient evidence of efficacy according to the study situation, are inflammatory (lichen sclerosus, acne) and infectious dermatoses (viral warts, cutaneous leishmaniasis, atypical mycobacteriosis).&#34;
        explanation: This review identifies acne as an emerging indication for photodynamic therapy with supportive evidence.
  - name: Nd:YAG laser and intralesional PRP
    description: &gt;
      Nd:YAG laser and intralesional platelet-rich plasma injections are used
      for inflammatory acne in split-face comparative protocols.
    treatment_term:
      preferred_term: therapeutic procedure of skin of body
      term:
        id: MAXO:0001417
        label: therapeutic procedure of skin of body
      qualifiers:
        - predicate:
            preferred_term: therapeutic procedure
            term:
              id: NCIT:C49236
              label: Therapeutic Procedure
          value:
            preferred_term: laser therapy
            term:
              id: NCIT:C15466
              label: Laser Therapy
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: platelet-rich plasma
            term:
              id: NCIT:C106557
              label: Platelet-rich Plasma
    evidence:
      - reference: PMID:35084634
        supports: SUPPORT
        snippet: &#34;The intralesional PRP injection and 1064 nm long-pulsed Nd:YAG laser are safe and effective methods for controlling inflammatory as well as non-inflammatory acne vulgaris in both adolescents and post-adolescent patients.&#34;
        explanation: This randomized split-face study supports Nd:YAG laser and PRP injections for inflammatory acne vulgaris.
  - name: 1726 nm laser therapy
    description: &gt;
      Targeted laser therapy that selectively affects sebaceous glands and is
      being evaluated for moderate to severe acne.
    treatment_term:
      preferred_term: laser surgical procedure
      term:
        id: MAXO:0001578
        label: laser surgical procedure
      qualifiers:
        - predicate:
            preferred_term: therapeutic procedure
            term:
              id: NCIT:C49236
              label: Therapeutic Procedure
          value:
            preferred_term: laser therapy
            term:
              id: NCIT:C15466
              label: Laser Therapy
        - predicate:
            preferred_term: therapeutic procedure
            term:
              id: NCIT:C49236
              label: Therapeutic Procedure
          value:
            preferred_term: infrared laser therapy
            term:
              id: NCIT:C66918
              label: Infrared Laser Therapy
    evidence:
      - reference: PMID:38271552
        supports: SUPPORT
        snippet: &#34;New 1726 nm lasers specifically target the sebaceous gland, which is known to be pivotal in acne pathophysiology.&#34;
        explanation: This review highlights 1726 nm lasers as a sebaceous gland-targeted treatment approach for acne.

clinical_trials:
  - name: NCT00421993
    phase: PHASE_III
    status: COMPLETED
    description: Multicenter, randomized, double-blind trial comparing adapalene/benzoyl peroxide gel with monotherapies and vehicle in acne vulgaris over 12 weeks.
    target_phenotypes:
      - preferred_term: comedonal acne
        term:
          id: HP:0040137
          label: Comedonal acne
      - preferred_term: erythematous papule
        term:
          id: HP:0030350
          label: Erythematous papule
      - preferred_term: pustule
        term:
          id: HP:0200039
          label: Pustule
    evidence:
      - reference: clinicaltrials:NCT00421993
        supports: SUPPORT
        snippet: &#34;This is a multi-center, randomized, double-blind, parallel group study with 12 weeks of treatment of acne vulgaris.&#34;
        explanation: The trial evaluates a combination topical therapy specifically in participants with acne vulgaris.
  - name: NCT02249767
    phase: PHASE_III
    status: COMPLETED
    description: Double-blind, randomized, parallel-group study assessing tretinoin gel bioequivalence in patients with mild acne vulgaris.
    target_phenotypes:
      - preferred_term: comedonal acne
        term:
          id: HP:0040137
          label: Comedonal acne
      - preferred_term: erythematous papule
        term:
          id: HP:0030350
          label: Erythematous papule
    evidence:
      - reference: clinicaltrials:NCT02249767
        supports: SUPPORT
        snippet: &#34;Normal, healthy male and female children and adults (i.e., ages 12 to 40 years) with at least Grade 2 (i.e., mild severity) acne vulgaris were treated on the full face once daily for 84 days with the Tretinoin Gel 0.05%, Brand (tretinoin) Gel 0.05%, or Gel Vehicle.&#34;
        explanation: This study explicitly enrolls participants with acne vulgaris and evaluates topical tretinoin treatment.

differential_diagnoses:
  - name: PAPASH syndrome
    disease_term:
      preferred_term: PAPASH syndrome
      term:
        id: MONDO:0958343
        label: PAPASH syndrome
    description: &gt;
      Autoinflammatory syndrome combining acne with pyoderma gangrenosum,
      hidradenitis suppurativa, and inflammatory arthritis.
    distinguishing_features:
      - Syndromic triad with pyoderma gangrenosum and hidradenitis suppurativa alongside acne.
      - Systemic inflammatory arthritis or other autoinflammatory features.
    evidence:
      - reference: PMID:41499625
        supports: SUPPORT
        snippet: &#34;PAPASH spectrum syndrome is a rare autoinflammatory condition encompassing psoriatic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa.&#34;
        explanation: This case report defines PAPASH syndrome as a syndromic condition including acne and related inflammatory diseases.
  - name: Rosacea
    disease_term:
      preferred_term: rosacea
      term:
        id: MONDO:0006604
        label: rosacea
    description: &gt;
      Chronic inflammatory facial dermatosis with papules and pustules but no comedones. Central facial erythema, flushing,
      and telangiectasias can mimic inflammatory acne on the face.
    distinguishing_features:
      - Absence of comedones with prominent centrofacial erythema and telangiectasias.
      - Burning or stinging with triggers such as heat, alcohol, or spicy foods rather than androgen-driven distribution.
    evidence:
      - reference: PMID:12113648
        supports: SUPPORT
        snippet: &#34;Localized pustular eruptions are seen on the hands and feet in adults with pustulosis palmaris et plantaris and acrodermatitis continua (both of which may be variants of psoriasis); on the face in patients with acne vulgaris, rosacea, and perioral dermatitis; and on the trunk and/or extremities in patients with folliculitis.&#34;
        explanation: The abstract lists rosacea alongside acne as a facial pustular eruption, underscoring the need for clinical differentiation.

  - name: Bacterial folliculitis
    disease_term:
      preferred_term: folliculitis
      term:
        id: MONDO:0006552
        label: folliculitis
    description: &gt;
      Infection or inflammation of hair follicles producing papules and pustules on hair-bearing skin, often the trunk or extremities,
      that can resemble acne lesions but lacks comedones and is frequently pruritic.
    distinguishing_features:
      - Lesions centered on hair follicles without open or closed comedones; often pruritic and may follow shaving or occlusion.
      - Distribution favors trunk, buttocks, and extremities rather than the typical facial and truncal comedones of acne.
    evidence:
      - reference: PMID:12113648
        supports: SUPPORT
        snippet: &#34;Localized pustular eruptions are seen on the hands and feet in adults with pustulosis palmaris et plantaris and acrodermatitis continua (both of which may be variants of psoriasis); on the face in patients with acne vulgaris, rosacea, and perioral dermatitis; and on the trunk and/or extremities in patients with folliculitis.&#34;
        explanation: The abstract notes folliculitis presents with pustular eruptions on the trunk or extremities, highlighting its overlap with acneiform lesions.
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Acne_Vulgaris.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>